Results 31 to 40 of about 41,567 (218)

Associations Between PSA Levels and Erectile Dysfunction in the Patient with LUTS

open access: yesMedicine Science, 2016
Erectile dysfunction (ED) are common problem in males with lower urinary tract symptoms suggestive (LUTS).The aim of this study is to evaluate whether there is an association between PSA levels and ED or not. This study included total of 54 males aged 45-
Huseyin Celik   +4 more
doaj   +1 more source

Clinical significance of prostate volume and testosterone reduction on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy

open access: yesScientific Reports, 2022
To investigate the effect of both prostate volume and serum testosterone changes on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy.
Woo Jin Bang   +5 more
doaj   +1 more source

Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments. [PDF]

open access: yes, 2019
BackgroundIrreversible Electroporation (IRE) is a novel image-guided tissue ablation technology that induces cell death via very short but strong pulsed electric fields.
Guenther, E   +6 more
core   +2 more sources

Correlation of Intravesical Prostatic Protrusion with Severity of Lower Urinary Tract Symptoms in Men With Symptomatic Benign Prostatic Hyperplasia at University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu

open access: yesNigerian Journal of Medicine
Background Benign prostatic hyperplasia (BPH) is one of the causes of lower urinary tract symptoms (LUTS) in men above 50 years of age. It is known that the severity of LUTS (degree of bladder outlet obstruction) does not correlate with the size of the ...
Chukwunonso Anthony Iwenofu   +4 more
doaj   +1 more source

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

open access: yesBlood Cancer Journal, 2023
Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines clinical ...
Wan-Hsuan Lee   +17 more
doaj   +1 more source

A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry [PDF]

open access: yes, 2017
Data on Myelodysplastic Syndromes (MDS) are difficult to collect by cancer registries because of the lack of reporting and the use of different classifications of the disease.
Agabiti, Nera   +25 more
core   +2 more sources

Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization [PDF]

open access: yes, 2017
PURPOSE: Phosphodiesterase type-5 inhibitor administration in diabetic men with erectile dysfunction (ED) is associated with reduced waist circumference.
Aversa, Antonio   +8 more
core   +1 more source

Evaluating ORB and SIFT With Neural Network as Alternatives to CNN for Traffic Classification in SDN Environments

open access: yesIEEE Access
Software-Defined Networking (SDN) centralizes control and separates the control plane from the data plane, enhancing flexibility and efficiency but also increasing the attack surface.
Hicham Yzzogh, Hafssa Benaboud
doaj   +1 more source

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire

open access: yesAdvances in Radiation Oncology, 2023
Purpose: The International Prostate Symptom Score (IPSS) is a widely used tool for evaluating patient-reported lower urinary tract symptoms. In this study, we assessed patients with prostate cancer and their understanding of IPSS questions.
Richard M. Gewanter, MD   +9 more
doaj   +1 more source

Exportin 1 Inhibitor Combined With Venetoclax Induces Apoptosis in Myelodysplastic Syndrome by Mitochondria‐Induced Apoptosis Pathway

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Inhibition of XPO1 is a promising modality in the treatment of MDS, especially when combined with Venetoclax, which activates mitochondria‐mediated apoptosis and could be a potential target for MDS therapy. ABSTRACT Background Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat.
Xiaohan Liu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy